-
Mashup Score: 2
Fossil fuel burning is a silent killer. The combustion of fossil fuels causes air pollution that is responsible for an estimated 350,000 premature deaths and…
Source: YouTubeCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Pediatric Core Curriculum Focuses on Lung Involvement in Neuromuscular Disease - ATSConferenceNews.org - 3 year(s) ago
Oren Kupfer, MD, opened the first of three sessions with an exploration of diagnostic strategies to identify NMDs as a prelude to managing and treating these diseases. “Respiratory disease is common in our patients with neuromuscular disease and is often the cause of death,” he said.
Source: ATSConferenceNews.orgCategories: Latest Headlines, PulmonologyTweet-
Neuromuscular disease was a focus of the Pediatric Clinical Core Curriculum sessions at #ATS2022. Read a recap in ATS Conference News and watch via On-Demand Highlights: https://t.co/Wll1RjoL2J @sandeeppuranik @PreroPulmSleep @ATSPeds https://t.co/alw5uPNrpJ
-
-
Mashup Score: 4Panel Examines Career Development Challenges in Wake of COVID-19 Pandemic - ATSConferenceNews.org - 3 year(s) ago
Jamuna K. Krishnan, MD, MBA, MSc; Neeta Thakur, MD, MPH; Juan C. Celedon, MD, DrPH, ATSF; and Sushma K. Cribbs, MD, MSCR, ATSF, discussed pre-existing threats to and the collateral effects of COVID-19 on professional development for young respiratory health faculty.
Source: ATSConferenceNews.orgCategories: Latest Headlines, PulmonologyTweet-
At #ATS2022, @jkkrishnanmd, @nthakurmd, @juancceledonmd, and @sushmacribbs discussed career development challenges in the wake of the COVID-19 pandemic. Read a recap in ATS Conference News and watch via On-Demand Highlights: https://t.co/0gcArWMVr0 https://t.co/xxHfck0zM9
-
-
Mashup Score: 2cAttendee - 3 year(s) agoSource: cattendee.abstractsonline.comCategories: Latest Headlines, PulmonologyTweet
-
Our #FeatureFriday is #ATS2022 On-Demand Highlights, available through June 24th! 💻https://t.co/0hYie1fxOD #meded https://t.co/xTZb56aioK
-
-
Mashup Score: 0
The virtual platform provides convenient, on-demand access to popular scientific sessions from the International Conference, including Year in Review and Core Curriculum sessions; industry presentations from leading companies in the field; and thousands of ePosters highlighting the latest discoveries in pulmonary, critical care, and sleep medicine.
Source: ATSConferenceNews.orgCategories: Latest Headlines, PulmonologyTweet-
#ATS2022 programming is coming to a close on Friday, June 24. Check out the On-Demand Highlights now, and mark your calendars for #ATS2023: https://t.co/YUuKnt4VSD @gregory1downey https://t.co/kS7frWmsJl
-
-
Mashup Score: 0Session Offers Patient, Clinician Perspectives on Long-Term Effects of COVID-19 - ATSConferenceNews.org - 3 year(s) ago
In addition to the physical effects of COVID-19 infection on patients, the pandemic has had a significant impact on the well-being of frontline health care workers. Experts including Heather De Keyser, MD, MSCR, discussed the implications of both for public health.
Source: ATSConferenceNews.orgCategories: Latest Headlines, PulmonologyTweet-
This #ATS2022 session looked at the lingering effects of COVID-19 on patients and care providers. Read a recap in ATS Conference News and watch via On-Demand Highlights: https://t.co/TGRbGpzz5N @crosassalazar @just_breathe_1 #longCOVID https://t.co/HXKPFPE5uF
-
-
Mashup Score: 4COVID-19 pandemic impacted youth vaping, cessation motivation - 3 year(s) ago
SAN FRANCISCO — A study of North Philadelphia high school students highlighted the COVID-19 pandemic’s effect on youth vaping patterns and cessation motivation, researchers reported at the American Thoracic Society International Conference.The National Youth Tobacco Survey reported a decrease in current e-cigarette use among high school students from 2019 to 2020 (27.5% vs. 19.6%) due
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
A study presented at #ATS2022 highlighted the impact that the #COVID19 pandemic had on youth #vaping patterns and cessation motivation @InfectDisNews @Klein_Jeremy https://t.co/J3NeMExstM
-
-
Mashup Score: 0
SAN FRANCISCO — Treatment with imatinib resulted in a sustained clinical benefit after 90 days in hospitalized patients with hypoxemic COVID-19, according to results of the CounterCOVID study.At the American Thoracic Society International Conference, Job R. Schippers, MD-PhD candidate for pulmonary medicine at Amsterdam University Medical Center, presented long-term clinical outcomes at 90
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
Treatment with imatinib resulted in sustained clinical benefit at 90 days in hypoxemic patients with #COVID19, according to results from the CounterCOVID study presented at #ATS2022 @InfectDisNews https://t.co/g8YitDdDWp
-
-
Mashup Score: 3Pulmonary Clinical Core Sessions Focus on Interstitial and Fibrotic Lung Diseases - ATSConferenceNews.org - 3 year(s) ago
Panelists Erica Farrand, MD; Bridget Collins, MD; Leticia Kawano-Dourado, MD, PhD; Ayodeji Adegunsoye, MD, MS; and Robert W. Hallowell, MD, explained the complexities of the diagnosis and treatment of diseases including pulmonary fibrosis and granulomatous lymphocytic interstitial lung disease, as well as autoimmune rheumatic diseases with pulmonary manifestations.
Source: ATSConferenceNews.orgCategories: Latest Headlines, PulmonologyTweet-
Presenters discussed interstitial and fibrotic lung diseases during the Pulmonary Clinical Core sessions at #ATS2022. Read a recap in ATS Conference News and watch via On-Demand Highlights: https://t.co/lqJqt8L7OU @ericafarrandMD @bridgetfcollins @leticiakawano @drdayjee https://t.co/MMSoUGYoEx
-
-
Mashup Score: 1Inhaled treprostinil improves persistence, lowers risk for PAH hospitalization vs. iloprost - 3 year(s) ago
SAN FRANCISCO — Inhaled treprostinil significantly improved persistence, adherence and lowered risk for hospitalization compared with iloprost in patients with pulmonary arterial hypertension, researchers reported.“For approved inhaled therapies, we have really two. Inhaled treprostinil is administered four times a day and iloprost must be administered six to nine times. The worry is
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
Researchers reported inhaled #treprostinil significantly improved persistence, adherence and lowered hospitalization risk vs. iloprost in patients with #PAH in a poster presented at #ATS2022 @CardiologyToday https://t.co/qTIvVSroFZ
-
Watch the #ATS2022 Keynote Address: Cutting Through the Smoke: Confronting the Climate Crisis Through Patient Care and Policy with @MaryRice_LungDr and @JohnKerry https://t.co/h1JOClMNP8 #climate #airpollution https://t.co/T2vYmDbtzu